About Leukoencephalopathy-spondyloepimetaphyseal dysplasia syndrome
Leukoencephalopathy-spondyloepimetaphyseal dysplasia syndrome is a rare disease catalogued by Orphanet (ORPHA:83629). It is associated with the AIFM1 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Leukoencephalopathy-spondyloepimetaphyseal dysplasia syndrome trials.
Search ClinicalTrials.gov for "Leukoencephalopathy-spondyloepimetaphyseal dysplasia syndrome" or filter by Orphanet code ORPHA:83629 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Leukoencephalopathy-spondyloepimetaphyseal dysplasia syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Leukoencephalopathy-spondyloepimetaphyseal dysplasia syndrome. Updated daily.